Amanda M. Farr

577 total citations
36 papers, 441 citations indexed

About

Amanda M. Farr is a scholar working on Infectious Diseases, Oncology and Epidemiology. According to data from OpenAlex, Amanda M. Farr has authored 36 papers receiving a total of 441 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 6 papers in Oncology and 5 papers in Epidemiology. Recurrent topics in Amanda M. Farr's work include HIV/AIDS Research and Interventions (8 papers), HIV/AIDS drug development and treatment (7 papers) and Diabetes Treatment and Management (4 papers). Amanda M. Farr is often cited by papers focused on HIV/AIDS Research and Interventions (8 papers), HIV/AIDS drug development and treatment (7 papers) and Diabetes Treatment and Management (4 papers). Amanda M. Farr collaborates with scholars based in United States, France and Australia. Amanda M. Farr's co-authors include Stephen S. Johnston, Suellen M. Curkendall, David M. Smith, John J. Sheehan, Iftekhar Kalsekar, George F. Duna, Beth Barber, Xue Song, Karina Raimundo and Gilwan Kim and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Blood.

In The Last Decade

Amanda M. Farr

36 papers receiving 429 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Amanda M. Farr United States	12	116	87	66	52	49	36	441
Jeremy Smith United States	13	121 1.0×	173 2.0×	67 1.0×	97 1.9×	22 0.4×	28	489
Morten Christoph Eike Norway	9	54 0.5×	36 0.4×	105 1.6×	9 0.2×	58 1.2×	15	493
Meghan Kapp United States	10	236 2.0×	51 0.6×	37 0.6×	45 0.9×	19 0.4×	32	488
Marı́a José Galindo Spain	16	466 4.0×	229 2.6×	30 0.5×	25 0.5×	24 0.5×	66	789
Jenny Sutherland Canada	10	15 0.1×	84 1.0×	79 1.2×	53 1.0×	49 1.0×	13	572
Xavier Badía Spain	14	31 0.3×	105 1.2×	46 0.7×	30 0.6×	92 1.9×	71	808
Luz-Ma-Adriana Balderas-Peña Mexico	13	27 0.2×	129 1.5×	29 0.4×	140 2.7×	156 3.2×	41	630
Luc J. J. Derijks Netherlands	22	43 0.4×	366 4.2×	27 0.4×	65 1.3×	15 0.3×	65	1.5k
Lauren E. Cain United States	11	109 0.9×	63 0.7×	46 0.7×	47 0.9×	21 0.4×	19	688
Evan Popoff United States	13	239 2.1×	104 1.2×	36 0.5×	56 1.1×	12 0.2×	43	567

Countries citing papers authored by Amanda M. Farr

Since Specialization

Citations

This map shows the geographic impact of Amanda M. Farr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amanda M. Farr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amanda M. Farr more than expected).

Fields of papers citing papers by Amanda M. Farr

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amanda M. Farr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amanda M. Farr. The network helps show where Amanda M. Farr may publish in the future.

Co-authorship network of co-authors of Amanda M. Farr

This figure shows the co-authorship network connecting the top 25 collaborators of Amanda M. Farr. A scholar is included among the top collaborators of Amanda M. Farr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amanda M. Farr. Amanda M. Farr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Felner, Jennifer K., et al.. (2020). “It’s Just a Band-Aid on Something No One Really Wants to See or Acknowledge”: A Photovoice Study with Transitional Aged Youth Experiencing Homelessness to Examine the Roots of San Diego’s 2016–2018 Hepatitis A Outbreak. International Journal of Environmental Research and Public Health. 17(13). 4721–4721. 10 indexed citations

Miller, Jeffrey D., Xin Ye, Gregory Lenhart, et al.. (2016). Cost-effectiveness of edoxaban versus rivaroxaban for stroke prevention in patients with nonvalvular atrial fibrillation (NVAF) in the US. ClinicoEconomics and Outcomes Research. 8. 215–215. 15 indexed citations

Rosenblatt, Lisa, et al.. (2016). Risk of cardiovascular events among patients with HIV treated with atazanavir-containing regimens: a retrospective cohort study. BMC Infectious Diseases. 16(1). 492–492. 5 indexed citations

Soliman, Ahmed M., Machaon Bonafede, Amanda M. Farr, Jane Castelli‐Haley, & Craig A. Winkel. (2016). Analysis of Adherence, Persistence, and Surgery Among Endometriosis Patients Treated with Leuprolide Acetate Plus Norethindrone Acetate Add-Back Therapy. Journal of Managed Care & Specialty Pharmacy. 22(5). 573–587. 4 indexed citations

Farr, Amanda M., et al.. (2016). Healthcare Costs Among Adults with Type 2 Diabetes Initiating DPP-4 Inhibitors. Advances in Therapy. 33(1). 68–81. 5 indexed citations

Johnston, Stephen S., Donna McMorrow, Amanda M. Farr, Paul Juneau, & Sarika Ogale. (2015). Comparison of Healthcare Costs Between Rheumatoid Arthritis Patients Treated with Infused Biologics After Switching from Another Biologic. Drugs - Real World Outcomes. 2(1). 99–109. 3 indexed citations

Thomas, Nina, et al.. (2015). The impact of persistence with therapy on inpatient admissions and emergency room visits in the US among patients with multiple sclerosis. Journal of Medical Economics. 19(5). 497–505. 27 indexed citations

Raimundo, Karina, Amanda M. Farr, Gilwan Kim, & George F. Duna. (2015). Clinical and Economic Burden of Antineutrophil Cytoplasmic Antibody–associated Vasculitis in the United States. The Journal of Rheumatology. 42(12). 2383–2391. 35 indexed citations

Farr, Amanda M., et al.. (2015). Persistence, adherence, and all-cause healthcare costs in atazanavir- and darunavir-treated patients with human immunodeficiency virus in a real-world setting. Journal of Medical Economics. 19(4). 386–396. 5 indexed citations

10.

Song, Xue, et al.. (2015). Overall survival in patients with metastatic melanoma. Current Medical Research and Opinion. 31(5). 987–991. 53 indexed citations

11.

Levin, Philip, et al.. (2015). Clinical and Economic Outcomes Associated With the Timing of Initiation of Basal Insulin in Patients With Type 2 Diabetes Mellitus Previously Treated With Oral Antidiabetes Drugs. Clinical Therapeutics. 38(1). 110–121. 8 indexed citations

12.

Alatorre, Carlos, et al.. (2015). Real‐World Dosing Patterns of Atomoxetine in Adults with Attention‐Deficit/Hyperactivity Disorder. CNS Neuroscience & Therapeutics. 21(12). 936–942. 8 indexed citations

13.

Farr, Amanda M., Yonghua Jing, Stephen S. Johnston, et al.. (2015). Comparison of hospital length of stay between hospitalized non-valvular atrial fibrillation patients treated with either apixaban or warfarin. Hospital Practice. 43(3). 172–179. 13 indexed citations

14.

Johnston, Stephen S., Timothy Juday, Amanda M. Farr, Bong-Chul Chu, & Tony Hebden. (2014). Comparison between guideline-preferred and nonpreferred first-line HIV antiretroviral therapy.. PubMed. 20(6). 448–55. 3 indexed citations

15.

Gatwood, Justin, Teresa B. Gibson, Michael E. Chernew, et al.. (2014). Price Elasticity and Medication Use: Cost Sharing Across Multiple Clinical Conditions. Journal of Managed Care Pharmacy. 20(11). 1102–1107. 17 indexed citations

16.

Duda, Stephany N., Amanda M. Farr, Mary Lou Lindegren, et al.. (2014). Characteristics and comprehensiveness of adult HIV care and treatment programmes in Asia‐Pacific, sub‐Saharan Africa and the Americas: results of a site assessment conducted by the International epidemiologic Databases to Evaluate AIDS (IeDEA) Collaboration. Journal of the International AIDS Society. 17(1). 19045–19045. 39 indexed citations

17.

Farr, Amanda M., John J. Sheehan, Suellen M. Curkendall, et al.. (2014). Retrospective Analysis of Long-Term Adherence to and Persistence with DPP-4 Inhibitors in US Adults with Type 2 Diabetes Mellitus. Advances in Therapy. 31(12). 1287–1305. 55 indexed citations

18.

Farr, Amanda M., et al.. (2014). No difference in persistence to treatment with atazanavir or darunavir in HIV patients in a real‐world setting. Journal of the International AIDS Society. 17(4S3). 19538–19538. 3 indexed citations

19.

Farr, Amanda M., Melissa A. Marx, Don Weiss, & Denis Nash. (2013). Association of neighborhood-level factors with hospitalization for community-associated methicillin-resistant Staphylococcus aureus, New York City, 2006: a multilevel observational study. BMC Infectious Diseases. 13(1). 84–84. 5 indexed citations

20.

Basch, Ethan, Johann S. de Bono, Howard I. Scher, et al.. (2012). Pain control and delay in time to skeletal-related events (SREs) in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with abiraterone acetate (AA): Long-term follow-up.. Journal of Clinical Oncology. 30(5_suppl). 183–183. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact